Fischer Imaging founder and chief technology officer Morgan Nields has resigned from his post, and from the company’s board of directors, effective December 31.
Nields will be concentrating his efforts on development and funding of Senolase, a company developing stereotactic breast tumor treatment technology. Nield’s resignation from the board follows the recent departures from the board of Teresa Ayers and Dr. David Bragg, according to the Denver-based vendor.
By AuntMinnie.com staff writersDecember 23, 2003
Related Reading
Fischer Imaging receives $1.2 million grant from National Cancer Institute, December 4, 2003
FDA clears Second Look with SenoScan, October 13, 2003
Fischer reports Q2 loss, but revenues grow, October 8, 2003
Fischer, Philips to develop mammo/US prototype, August 12, 2003
Fischer offers restated results, July 17, 2003
Copyright © 2003 AuntMinnie.com
